MITOCHONDRIAL DNA TRNALEU(UUR) M.3243A<G MUTATION

Clinical trials for MITOCHONDRIAL DNA TRNALEU(UUR) M.3243A<G MUTATION explained in plain language.

Never miss a new study

Get alerted when new MITOCHONDRIAL DNA TRNALEU(UUR) M.3243A<G MUTATION trials appear

Sign up with your email to follow new studies for MITOCHONDRIAL DNA TRNALEU(UUR) M.3243A<G MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Hope for mitochondrial disease patients: new drug targets debilitating fatigue

Symptom relief Recruiting now

This study is testing whether a medicine called sonlicromanol can reduce fatigue and improve physical abilities like balance and leg strength in adults with a specific type of mitochondrial disease. About 220 participants will take either the real medicine or a placebo pill twice…

Matched conditions: MITOCHONDRIAL DNA TRNALEU(UUR) M.3243A<G MUTATION

Phase: PHASE3 • Sponsor: Khondrion BV • Aim: Symptom relief

Last updated Mar 30, 2026 14:28 UTC

MITOCHONDRIAL DNA TRNALEU(UUR) M.3243A<G MUTATION

Get alerted when new MITOCHONDRIAL DNA TRNALEU(UUR) M.3243A<G MUTATION trials appear

Hope for mitochondrial disease patients: new drug targets debilitating fatigue